BackBrooklyn ImmunoTherapeutics Overview

Brooklyn ImmunoTherapeutics Other Income Expense Net

Other Income/Expense Net for BTX.

Quarterly Other Income/Expense

-$24.33M
↓ 121765% YoY

As of Sep 30, 2024

Annual Other Income/Expense (TTM)

-$26.18M
↓ 11482.3% YoY

Trailing 12 months ending Sep 30, 2024

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin